Stay updated with breaking news from ஜிம் குஸ்டாஃப்சன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator Good evening. My name is Missy and I will be your conference facilitator today. At this time, I would like to welcome everyone to the DaVita Second Quarter 2021 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers remarks, there will be a question-and-answer period. [Operator Instructions] Thank you, Mr. Gustafson. You may begin your conference. Jim Gustafson Vice President, Investor Relations Thank you and welcome everyone to our second quarter conference call. We appreciate your continued interest in our company. I m Jim Gustafson, Vice President of Investor Relations and joining me today are Javier Rodriguez, our CEO; and Joel Ackerman, our CFO. ....
DaVita Inc. 2nd Quarter 2021 Results prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
DaVita Inc. Schedules 2nd Quarter 2021 Investor Conference Call prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article Share this article DENVER, April 29, 2021 /PRNewswire/ DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2021. For the quarter, diluted earnings per share from continuing operations was $2.09, an increase of 15.5% from the prior year diluted earnings per share from continuing operations and an increase of 14.2% from the prior year adjusted diluted earnings per share from continuing operations. First quarter diluted earnings per share from continuing operations was impacted by the challenges of responding to COVID-19, with an estimated net impact on operating income of approximately $(35) million. This impact was primarily driven by higher patient mortality due to COVID-19 and the high cost of personal protective equipment, partially offset by a benefit from the temporary suspension of Medicare sequestration cuts. ....